INST OX-05-024: first line gemcitabine, oxaliplatin, and erlotinib for primary hepatocellular carcinoma and bile duct cancers: a multicenter Phase II trial
Yehuda Z. Patt, Waheed Murad, Mohammed H. Fekrazad, Ari D. Baron, Pranshu Bansal, Yanis Boumber, Kim Steinberg, Sang Joon Lee, Ed Bedrick, Ruofei Du, Fa Chyi Lee
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'INST OX-05-024: first line gemcitabine, oxaliplatin, and erlotinib for primary hepatocellular carcinoma and bile duct cancers: a multicenter Phase II trial'. Together they form a unique fingerprint.